RXSTUDY CARD
Live / Registered — Registered (as of 23 Jul 2024)
What this means for you
Registered since 23 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98275211
- Registration number
- 7458894
- Mark type
- Stylized text
- Filed
- 17 Nov 2023
- Registered
- 23 Jul 2024
- Attorney of record
- Larry L. Coats
Goods and services
- Class 035 — Advertising and business services: The bringing together, for the benefit of others, of clinical study medications and related supplies, excluding the transport thereof, enabling customers, in particular, clinical study sponsors, contact research organizations and study sites, to conveniently purchase those goods by means of wholesalers, retail and specialty pharmacies
- Class 036 — Insurance and financial services: Payment processing services utilizing health insurance prescription benefit claims platforms that allow pharmacies to facilitate reimbursement payments for commercially available medication and supplies provided in support of clinical trials; clinical payment processing services utilizing health insurance medical benefit claims platforms that allow health care providers to facilitate reimbursement payments for commercially available medication, supplies and services rendered or provided in support of clinical trials
Owner
- Mercalis Inc., Morrisville, NC, US
- Mercalis Inc., Morrisville, NC, US
Prior registrations
Prosecution history
- 23 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Jul 2024 — REGISTERED-SUPPLEMENTAL REGISTER
- 14 Jun 2024 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 14 Jun 2024 — EXAMINER'S AMENDMENT ENTERED
- 14 Jun 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Jun 2024 — EXAMINERS AMENDMENT E-MAILED
- 14 Jun 2024 — EXAMINERS AMENDMENT -WRITTEN
- 11 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Jun 2024 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 20 May 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 20 May 2024 — FINAL REFUSAL E-MAILED
- 20 May 2024 — FINAL REFUSAL WRITTEN
- 15 May 2024 — ASSIGNED TO EXAMINER
- 29 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED